These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 8491094)

  • 1. The functional neuroanatomy of corticotropin-releasing factor.
    Sawchenko PE; Imaki T; Potter E; Kovács K; Imaki J; Vale W
    Ciba Found Symp; 1993; 172():5-21; discussion 21-9. PubMed ID: 8491094
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of corticotropin-releasing factor mRNA in neuroendocrine and autonomic neurons by osmotic stimulation and volume loading.
    Imaki T; Vale W; Sawchenko PE
    Neuroendocrinology; 1992 Nov; 56(5):633-40. PubMed ID: 1488095
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pituitary adenylate cyclase-activating peptide gene expression in corticotropin-releasing factor-containing parvicellular neurons of the rat hypothalamic paraventricular nucleus is induced by colchicine, but not by adrenalectomy, acute osmotic, ether, or restraint stress.
    Hannibal J; Mikkelsen JD; Fahrenkrug J; Larsen PJ
    Endocrinology; 1995 Sep; 136(9):4116-24. PubMed ID: 7649120
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Local Corticotropin-Releasing Factor Signaling in the Hypothalamic Paraventricular Nucleus.
    Jiang Z; Rajamanickam S; Justice NJ
    J Neurosci; 2018 Feb; 38(8):1874-1890. PubMed ID: 29352046
    [TBL] [Abstract][Full Text] [Related]  

  • 5. C-fos mRNA pattern and corticotropin-releasing factor neuronal activity throughout the brain of rats injected centrally with a prostaglandin of E2 type.
    Lacroix S; Valliéres L; Rivest S
    J Neuroimmunol; 1996 Nov; 70(2):163-79. PubMed ID: 8898725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distribution of corticotropin-releasing factor binding protein-immunoreactivity in the rat hypothalamus: association with corticotropin-releasing factor-, urocortin 1- and vimentin-immunoreactive fibres.
    Henry BA; Lightman SL; Lowry CA
    J Neuroendocrinol; 2005 Mar; 17(3):135-44. PubMed ID: 15796765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence for local corticotropin releasing factor (CRF)-immunoreactive neuronal circuits in the paraventricular nucleus of the rat hypothalamus. An electron microscopic immunohistochemical analysis.
    Liposits Z; Paull WK; Sétáló G; Vigh S
    Histochemistry; 1985; 83(1):5-16. PubMed ID: 3900007
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypertensive rats exhibit heightened expression of corticotropin-releasing factor in activated central neurons in response to restraint stress.
    Krukoff TL; MacTavish D; Jhamandas JH
    Brain Res Mol Brain Res; 1999 Feb; 65(1):70-9. PubMed ID: 10036309
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Localization, colocalization, and plasticity of corticotropin-releasing factor immunoreactivity in rat brain.
    Sawchenko PE; Swanson LW
    Fed Proc; 1985 Jan; 44(1 Pt 2):221-7. PubMed ID: 2981743
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chlordiazepoxide attenuates stress-induced accumulation of corticotropin-releasing factor mRNA in the paraventricular nucleus.
    Imaki T; Vale W
    Brain Res; 1993 Oct; 623(2):223-8. PubMed ID: 8221103
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adrenalectomy-induced enhancement of CRF and vasopressin immunoreactivity in parvocellular neurosecretory neurons: anatomic, peptide, and steroid specificity.
    Sawchenko PE
    J Neurosci; 1987 Apr; 7(4):1093-106. PubMed ID: 3553442
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of peptide histidine-isoleucine/vasoactive intestinal polypeptide-immunoreactive neurons in the central nervous system with special reference to their relation to corticotropin releasing factor- and enkephalin-like immunoreactivities in the paraventricular hypothalamic nucleus.
    Hökfelt T; Fahrenkrug J; Ju G; Ceccatelli S; Tsuruo Y; Meister B; Mutt V; Rundgren M; Brodin E; Terenius L
    Neuroscience; 1987 Dec; 23(3):827-57. PubMed ID: 3125490
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibers in the rat brain: an immunohistochemical study.
    Swanson LW; Sawchenko PE; Rivier J; Vale WW
    Neuroendocrinology; 1983; 36(3):165-86. PubMed ID: 6601247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of leptin on corticotropin-releasing factor (CRF) synthesis and CRF neuron activation in the paraventricular hypothalamic nucleus of obese (ob/ob) mice.
    Huang Q; Rivest R; Richard D
    Endocrinology; 1998 Apr; 139(4):1524-32. PubMed ID: 9528930
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamic acid decarboxylase- and gamma-aminobutyric acid-like immunoreactivities in corticotropin-releasing factor-containing parvocellular neurons of the hypothalamic paraventricular nucleus.
    Meister B; Hökfelt T; Geffard M; Oertel W
    Neuroendocrinology; 1988 Nov; 48(5):516-26. PubMed ID: 3072487
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Corticotropin-releasing factor synapses within the paraventricular nucleus of the hypothalamus.
    Silverman AJ; Hou-Yu A; Chen WP
    Neuroendocrinology; 1989 Mar; 49(3):291-9. PubMed ID: 2785663
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intracerebroventricular administration of corticotropin-releasing factor antagonist attenuates c-fos mRNA expression in the paraventricular nucleus after stress.
    Imaki T; Shibasaki T; Wang XQ; Demura H
    Neuroendocrinology; 1995 Apr; 61(4):445-52. PubMed ID: 7783858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dexfenfluramine on the transcriptional activation of CRF and its type 1 receptor within the paraventricular nucleus of the rat hypothalamus.
    Laflamme N; Bovetto S; Richard D; Rivest S
    Br J Pharmacol; 1996 Mar; 117(6):1021-34. PubMed ID: 8882592
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution and origin of corticotropin-releasing factor-immunoreactive axons in the female rat lumbosacral spinal cord.
    Puder BA; Papka RE
    J Neurosci Res; 2001 Dec; 66(6):1217-25. PubMed ID: 11746455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of basal corticotropin-releasing hormone and arginine vasopressin messenger ribonucleic acid expression in the paraventricular nucleus: effects of selective hypothalamic deafferentations.
    Herman JP; Wiegand SJ; Watson SJ
    Endocrinology; 1990 Nov; 127(5):2408-17. PubMed ID: 2171915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.